On October 30, 2024, New Jersey Governor Murphy signed into law Assembly Bill 4447, which expands the permissible exceptions for a health care practitioner to self-refer. The Codey Law prohibits healthcare practitioners from referring patients for a health care service in which the practitioner or the practitioner’s immediate family has a significant beneficial interest. This new exception to the Codey Law allows oncology practitioners with a financial interest in a pharmacy integrated with their practice to refer patients to that pharmacy, as long as the pharmacy:
• dispenses medications exclusively to the practice’s patients;
• has direct access to the practice’s medical records;
• communicates with each patient in person or via telemedicine to review the prescription instructions and assesses the patient for interactions with other drugs and food;
• synchronously consults with the treating physicians as needed; and
• complies with the State Board of Pharmacy requirements for timely delivery of medications, hours of operation, and recordkeeping.